NCT00137540View on ClinicalTrials.gov

FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

July 31, 2008

Conditions
Atrial Fibrillation
Interventions
DEVICE

RF ablation

DRUG

anti-arrhythmic drug therapy

All Listed Sponsors
lead

Biosense Webster EMEA

INDUSTRY

NCT00137540 - FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT) | Biotech Hunter | Biotech Hunter